Act Capital Management, LLC Akero Therapeutics, Inc. Transaction History

Act Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$8.0 - $15.01 $80,000 - $150,100	-10,000 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$12.97 - $22.26 $45,395 - $77,910	-3,500 Reduced 25.93%	10,000 $142,000
Q4 2021 Feb 03, 2022	SELL	$19.87 - $26.24 $188,765 - $249,279	-9,500 Reduced 41.3%	13,500 $286,000
Q3 2021 Nov 16, 2021	BUY	$18.65 - $25.46 $428,949 - $585,580	23,000 New	23,000 $514,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.33B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Act Capital Management, LLC with notifications on news.